Case Digest on Amgen Inc. et al. v. Sanofi et al.
This case centers on the patentability and legal protection of biotechnological innovations, specifically engineered antibodies that help reduce low-density lipoprotein (LDL) cholesterol. The core legal principle involves the standards for patent validity in the context of biopharmaceuticals, focusing on the balance between innovation protection and public access to medical advancements.